Boiron Laboratories: Positive 2025 Half-Year Report

Laboratoires Boiron reported higher results for the first half of 2025. Sales totaled €245,647,000, an increase of 7.6% compared to 2024. This increase was primarily driven by sales in North America, up 23.1% thanks to the flu pandemic, and in the "Other Countries" region, with growth of 46% driven by Asia and Brazil. However, sales in Europe excluding France declined by 3.9%, impacted by lower sales in Spain and Italy.

Operating profit reached €15,673,000, an increase of 221.5%. Advertising costs increased in the United States and Asia, reflecting the expansion of these markets. The group's net profit increased by 241.1% to €11,364,000, with a stable tax rate.

For the remainder of the year, performance will depend on global economic conditions and seasonal illnesses. Boiron is committed to promoting homeopathy and its health solutions for a more sustainable system.